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Feline infectious peritonitis (FIP), caused by feline coronavirus (FCoV) infection, is a highly lethal disease without
effective therapy and prevention. With an immune-mediated disease entity, host genetic variant was suggested to
influence the occurrence of FIP. This study aimed at evaluating cytokine-associated single nucleotide polymorphisms
(SNPs), i.e., tumor necrosis factor alpha (TNF-α), receptor-associated SNPs, i.e., C-type lectin DC-SIGN (CD209), and
the five FIP-associated SNPs identified from Birman cats of USA and Denmark origins and their associations with
the outcome of FCoV infection in 71 FIP cats and 93 FCoV infected non-FIP cats in a genetically more diverse cat
populations. A promoter variant, fTNFA - 421 T, was found to be a disease-resistance allele. One SNP was identified
in the extracellular domain (ECD) of fCD209 at position +1900, a G to A substitution, and the A allele was associated
with FIP susceptibility. Three SNPs located in the introns of fCD209, at positions +2276, +2392, and +2713, were
identified to be associated with the outcome of FCoV infection, with statistical relevance. In contrast, among the
five Birman FIP cat-associated SNPs, no genotype or allele showed significant differences between our FIP and
non-FIP groups. As disease resistance is multifactorial and several other host genes could involve in the development
of FIP, the five genetic traits identified in this study should facilitate in the future breeding of the disease-resistant
animal to reduce the occurrence of cats succumbing to FIP.Introduction
Feline infectious peritonitis (FIP), a highly lethal disease
with nearly 100% mortality among ill cats once clinical
signs appear, is caused by feline coronavirus (FCoV) infec-
tion [1]. Despite the ubiquitous existence of FCoV around
the world, the prevalence of FIP is less than 5% [2]. There
is currently no therapy proven to be effective for the
treatment of FIP, and once diagnosis is confirmed, euthan-
asia is generally inevitable. Although this disease has been
described for over fifty years [3], studies attempting to
develop vaccines with different approaches have all failed
due to the immunopathogenic features of infection by this
virus [4]. However, among many FCoV experimental
inoculations studies, some cats survived challenge with
the virulent strain of FCoV [2,5-10], whereas certain* Correspondence: linglingchueh@ntu.edu.tw
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unless otherwise stated.pedigreed cats were reported to be more likely to suc-
cumb to FIP than mixed bred cats [2,11,12]. All these
findings indicate that genetic polymorphisms between
cats might affect their susceptibility to FIP.
FIP is an immunopathological consequence of the abnor-
mal production of various cytokines. Imbalanced Th1/Th2
immune responses with scarce or absent interferon-gamma
(IFN-γ) is consistently found in FIP cases [4,8,10,13-15]
and association of genetic polymorphisms in the IFN-γ
gene with FIP occurrence has recently been identified
[16]. In addition to IFN-γ, the upregulation of tumor ne-
crosis factor-alpha (TNF-α) during the development of
FIP has been reported to result in lymphopenia [17]. Fe-
line dendritic cell (DC)-specific intercellular adhesion
molecule-grabbing non-integrin (fDC-SIGN, encoded
by fCD209), a key coreceptor during the infection of
both type I and II FCoV [18], was found to affect binding
and infection of type I FCoV. fDC-SIGN is also involved
in the infection of type II FCoV, albeit not through the
initial binding [19]. Despite the close relationship to FCoVtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(fTNFA) genes and their association with FIP occurrence
have never been investigated.
Recently, the surveillance of FIP-associated single nu-
cleotide polymorphisms (SNPs) in Birman cats from USA
and Denmark was conducted using a commercialized
feline SNP array [20], and five SNPs were found to be
significantly associated with FIP occurrence. However,
it is unclear whether these disease-associated SNPs are
Birman cat specific or can also be applied to other
purebred or mixed breed cat populations.
To elucidate the genetic traits that contribute to FIP
susceptibility, the fTNFA and fCD209 genes were screened
to identify disease-associated SNPs. The five SNPs
identified from Birman cats proposed to be genetically
associated with the occurrence of FIP were further
evaluated in populations with more variable genetic
backgrounds. Among all the polymorphisms analyzed,
SNPs located in the fTNFA and fCD209 genes were
found to be associated with the outcome of FCoV infec-
tion, with statistical relevance.
Materials and methods
Animals and specimens
Samples were collected from 71 FIP cats and 93 FCoV-
infected asymptomatic cats from 2005 to 2014 at the
National Taiwan University Animal Hospital for an asso-
ciation analysis. This study required no specific ethical
approval, as the analysis was performed retrospectively
from samples of diseased animals routinely submitted to
our diagnostic laboratory.
Seventy-one FIP cats, including 35.2% (25/71) pure-
bred and 64.8% (45/71) mixed breed, were confirmed by
necropsy. Pedigree cats including Scottish Fold (6/25),
American Shorthair (4/25), Chinchilla (3/25), Exotic Short-
hair (3/25), Siamese (2/25), European Shorthair (1/25) and
Russian Blue (1/25). Most of the FIP cats (46/71) were less
than one years old, the other 19 FIP cats were between the
ages of one and three. The rest six FIP cats elder thanTable 1 Primers used for SNP identification of fTNFA and fCD
Target gene/region Positiona Orientationb
fTNFA/5′-PRRd −847 to −827 F
+171 to +153 R
fCD209/5′-PRR −1057 to −1038 F
+19 to +1 R
fCD209/ECDe +1818 to +1838 F
+3168 to +3149 R
aThe nucleotide positions are numerated from the translation start point (+1).
bF: forward; R: reverse.
cAnnealing temperature.
d5′-proximal regulatory region.
eExtracellular domain.three were from 3.5 to 10 years old. Also, FCoV detection
by reverse transcription-nested polymerase chain reaction
(RT-nPCR) [21] was confirmed in disease-associated
tissue, including body effusions and/or internal organs
with the typical lesions of FIP. Ninety-three asymptomatic
healthy cats were included as a control group, including
75.3% (50/93) mixed breed and 24.7% (23/93) purebred, of
an age of three years old or less and showing no FIP-
related signs upon enrolment in this study. Pedigree cats
including American Shorthair (8/23), Scottish Fold (7/23),
Chinchilla (4/23), Persian (2/23), Abyssinian (1/23) and
European Shorthair (1/23). All the asymptomatic cats
were positive for FCoV detection in at least one sample
collected, including whole blood, nasal/oral/conjunctival/
rectal swabs, and feces. In addition, the detection of two
feline retroviruses, i.e., feline leukemia virus and feline
immunodeficiency virus, was performed [22,23]. FIP cats
and FCoV infected non-FIP cats with a positive result
for either of the feline retroviruses were excluded from
the association study.
Identification of SNPs in target sequences
Genomic DNA was isolated from buccal swabs or whole
blood samples from each cat using a genomic DNA mini
kit (Geneaid Biotech, New Taipei City, Taiwan). Partial
fTNFA and fCD209 sequences and five FIP-associated
SNPs identified in Birman cats, as reported by Golovko
et al., namely, A1.196617776, A1.206840008, Un.59861682,
A2.191286425, and E2.65509996, were amplified [20] using
the polymerase chain reaction (PCR). The primers and con-
ditions are listed in Tables 1 and 2. Briefly, each reaction
contained 1 μL of template DNA, 500 nM of each primer,
200 μM dNTP, 1.5 mM MgCl2, and 0.6 U Phusion DNA
polymerase (Thermo Scientific, Waltham, USA) in a
total volume of 30 μL with 1× Phusion HF buffer. The
amplified products were subsequently sequenced using
an auto-sequencer ABI 3730XL (Applied Biosystems, San
Mateo, USA), and the obtained sequences were aligned by
Geneious 4.8.5 (Biomatters, Auckland, New Zealand). The209 gene
Sequence (5′ - 3′) TA
c Amplicon size
GAATTCCCAGGGTTGCTTTCA 65 °C 1018 bp
GCCGATCACTCCAAAGTGC
GAAGCGGGCTTCTTGTTGAC 65 °C 1076 bp
GCTCCTTGGGGTCACACAT
CCAAGATCTGATGCATCTGCT 67 °C 1350 bp
ATGAGCTCGTTGCCTGATCT
Table 2 Primers used for SNP identification of five suspected FIP-associated SNPs in Birman cats
SNP name Chr-SNP positiona Orientationb Sequence (5′ - 3′) TA
c Amplicon size
A1.196617776 A1-154265118 F GGCAGTCAGAGAATGAGACAC 61 °C 337 bp
R TTGCCAGTTCTGCAGATTG
A1.206840008 A1-164728174 F AGGTGAAGTGTTGTGTGCAT 61 °C 388 bp
R ATGTTCTGCTAGATGAGCCG
Un.59861682 A1-155715831 F CTCATCCCAGTTGATCACAC 61 °C 230 bp
R TTCCTCCTGGAAAACCCT
A2.191286425 A2-126618108 F AGCGTATCAAGTGCCTGC 61 °C 299 bp
R CCTTCCTGTTTAGGTGCTTG
E2.65509996 E2-54165589 F CGCTTCAGTTTCCTTTCCAG 61 °C 417 bp
R TCTGAGCCTTGGTCTTCTG
aChr: chromosome.
bF: forward; R: reverse.
cAnnealing temperature.
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positions of the SNPs are numerated from the translation
start point (+1).
Association analysis
The association between the targeted SNPs and the occur-
rence of FIP was analyzed using Fisher’s exact test, and a
P value < 0.05 was considered to be a significant association.
Results
Polymorphism at fTNFA - 421 was found to be
significantly associated with resistance to FIP
Because the overproduction of TNF-α is widely reported
in FIP animals and is considered to contribute to the patho-
genesis of FIP, we first screened the polymorphisms at
the 5′ terminus of the fTNFA gene, including the prox-
imal regulatory region (PRR), the 5′-untranslated region
(UTR), and part of exon 1, in 71 FIP and 93 control cats.
Eight SNPs and three repeat regions were identified in
the analyzed 1018 bp (Figure 1). One SNP located in exonFigure 1 A schematic of the 5′ terminal of the fTNFA gene analyzed in
this study, including the PRR, the 5′-UTR, and part of exon 1. All the SNPs and
Black boxes: repeat regions. SNPs located in the exon were shaded.1 at position +23 results in the substitution of CGG to
CAG, causing an amino acid change from Arg to Gly
(R8G); the remaining SNPs were found in the PRR. The
mean allele frequencies of the minor alleles ranged from
4.3% to 39.9%. To examine the association between the
identified SNPs in fTNFA and the outcome of FCoV
infection, the frequency of each genotype and allele was
analyzed (Additional file 1). Only one allele (T allele) at
position −421 appeared to be significantly associated
with resistance to FIP (P = 0.009, OR = 3.925), whereas
the others showed no significance to the disease (Table 3
and Additional file 1).
Polymorphisms in the extracellular domain and introns 6
and 7 of fCD209 were found to be significantly associated
with the disease outcome
fCD209 is an important co-receptor for both type I and
II FCoV infection. To demonstrate an association between
polymorphisms and FIP, we sequenced polymorphisms of
the PRR, 5′-UTR, and extracellular domain (ECD) ofthis study. A partial fTNFA sequence of 1018 bp was sequenced in
the corresponding positions are indicated with lines. Gray box: exon 1.
Table 3 FIP-associated genetic polymorphisms identified in the fIFNG, fTNFA, and fCD209 gene and their associations
with FIP
Target gene/position Susceptible allele Resistant allele P value ORa Reference
fIFNG +428 C T 0.03 3.4 (1.1-10.3) [16]
fTNFA - 421 C T 0.009 3.9 (1.3-11.8) This study
fCD209 + 1900 A G 0.014 3.7 (1.3-10.5) This study
fCD209 + 2276 C T 0.038 NAb This study
fCD209 + 2392 G A 0.016 2.6 (1.2-5.5) This study
fCD209 + 2713 T C 0.039 1.75 (1.1-2.9) This study
aOdds Ratio.
bNot available.
Wang et al. Veterinary Research 2014, 45:123 Page 4 of 7
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and one AG repeat region were identified in the PRR,
and one SNP was found in the 5′-UTR (Figure 2). Fur-
thermore, polymorphism screening of ECD, revealed
25 SNPs and a G repeat in the 1350-bp region analyzed
(Figure 2). Four SNPs were located in exons, including
two SNPs in exon 6 at positions +1900 (TGG > TAG,
W128*) and +1952 (AAC > AAA, N145K), one in exon
7 at position +2498 (ACG>ACT, T178T), and one in exon
8 at position +3070 (TTC >TCC, F241S). The remaining
21 SNPs were located in introns 6 and 7 (Figure 2). The
mean allele frequencies of the minor alleles ranged from
0.6% to 47.6%.
To further demonstrate the association between the
identified SNPs in fCD209 and the outcome of FCoV in-
fection, the frequency of each genotype and allele was ana-
lyzed. Among the 24 SNPs analyzed in the PRR and the
5′-UTR of the fCD209 gene, no genotype or allele showed
a significant association with the outcome of the infection
(Additional file 2). In contrast, four SNPs, +1900 in the
ECD of exon 6, +2276 and +2392 in intron 6, and +2713
in intron 7, identified in fCD209 were found to be signifi-
cantly associated with FIP. fCD209 + 1900, located in the
ECD, which is characterized by a G-to-A substitution thatFigure 2 A schematic of the partial fCD209 gene analyzed in this stud
study. All the SNPs and the corresponding positions were indicated with lin
SNPs located in the exon were shaded.leads to a premature stop codon (TGG > TAG, W128*),
had a significantly increased frequency in FIP animals
(18.31%) compared with the control animals (5.38%)
(P = 0.011, OR = 3.95), and the A allele was shown to be
significantly associated with susceptibility to FIP (P = 0.014,
OR = 3.65) (Table 3 and Additional file 2). Furthermore,
three SNPs, +2276, +2392, and +2713, located in introns 6
and 7 were found to be associated with disease susceptibil-
ity. A higher frequency of the T allele at position +2276
in the control cats was significantly associated with re-
sistance to FIP (P = 0.038). Similarly, the A allele at pos-
ition +2392, with a higher frequency in FCoV-infected
asymptomatic cats, showed a significant association
with disease resistance (P = 0.016, OR = 2.57). Moreover,
the T allele at position +2713 was identified with a higher
frequency in FIP cats, showing a significant association
with disease susceptibility (P = 0.039, OR = 1.75) (Table 3
and Additional file 2).
Evaluation of the association between the FIP-associated
SNPs reported in Birman cats and disease susceptibility in
a cat population with higher genetic variability
Five SNPs were reported to be associated with the oc-
currence of FIP in Birman cats in a recent study usingy. The PRR, the 5′-UTR, and the ECD of fCD209 were sequenced in this
es. Gray boxes: exons. Black boxes: repeat regions. White box: 5′ UTR.
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of information concerning the nucleotide sequence of
the SNPs, the sequences were identified. The nucleotide
sequences of A1.196617776, A1.206840008, Un.59861682,
A2.191286425, and E2.65509996 consisted of C/A, G/A,
G/A, C/T, and C/T, respectively. To test for an association
of these SNPs with the occurrence of FIP also applies to
other breeds of cats, the frequency of each genotype and
allele of the targeted SNPs was analyzed in all the FIP and
control cats enrolled in this study, i.e., 29.3% purebred
and 70.7% mixed breed. Among the five SNPs analyzed,
neither the genotype nor allele percentage showed a
significant association with the outcome of the disease
(Additional file 3).
Association study
Among all the FIP animals analyzed in this study, 64 (64/
71, 90.1%) cats were found to be effusive form (wet), and
the rest seven of them (7/71, 9.9%) were non-effusive (dry).
The association between the identified FIP-related SNPs
(fTNFA - 421, fCD209 + 1900, + 2276, + 2392 and +2713)
and the form of FIP were analyzed. None of the SNPs was
found to be associated with the biotype of FIP.
The number of the FIP-associated SNPs harbored is
correlated to the disease outcome
This study attempted to distinguish multiple genetic traits
associated with FIP susceptibility. The FIP-associated
genetic polymorphisms identified in the fIFNG [16],
fTNFA, and fCD209 genes are summarized in Table 3.
Moreover, the association between the number of FIP-
associated SNPs harbored, including resistant or suscep-
tible genotype/alleles identified at fIFNG +428, fTNFA -
421, and fCD209 + 1900, + 2276, + 2392, and +2713, and
the occurrence of FIP, was analyzed in this study (Table 4).
The number of FIP-resistant SNPs carried was found to be
associated with the protection of cats from FIP (P = 0.002),
and the odds ratios of FIP and non-FIP cats carrying one
or more (≥ 2) resistance SNPs were 3.06 and 6.01, respect-
ively; this result indicates that cats carrying more resistant
SNPs appear to have a lower chance of developing FIP.Table 4 Association of the number of the disease-associated
fCD209 + 1900, + 2276, + 2392, and +2713, and the outcome o
Genotypes/alleles harbored FIP number (%) No
Resistant SNPs
= 0 59 (83.1%) 54
= 1 10 (14.1%) 28
≥ 2 2 (3%) 11
Susceptible SNPs
= 0 35 (49.3%) 66
≥ 1 36 (50.7%) 27However, the FIP cats were identified with a higher fre-
quency as carrying more than one FIP-susceptible SNP
(50.7%) than the control cats (29.0%), showing a significant
association with disease susceptibility (P = 0.0059,
OR = 2.51) (Table 4).
Discussion
FIP is an important infectious disease in cats, with nearly
100% mortality. However, an understanding of the host
determinants in the occurrence of FIP has been limited
to date. An imbalance between cellular and humoral
immunity - with excess antibodies contributing to disease
progression [4,24] and a significant decrease in IFN-γ pro-
duction [4,8,10,13-15] - has been consistently observed in
FIP animals. We recently identified the first host gene –
fIFNG – showing an association between host genetic
polymorphisms and FIP [16]. A T allele at fIFNG +428
was identified as a resistant allele, and the heterozygous
genotypes (CT) at positions +401 and +408 were identified
as associated with susceptibility to type I FCoV-induced
FIP. In this study, five additional SNPs from fTNFA and
fCD209 were identified.
During the development of FIP, the upregulation of
TNF-α, an important pro-inflammatory cytokine, has
been consistently found [4,17,24,25]. The overproduction
of TNF-α induces apoptosis in CD8+ T cells and is associ-
ated with the upregulation of a type II FCoV receptor,
i.e., feline aminopeptidase N, which accelerates macro-
phage infection by the virus [26]. Moreover, TNF-α to-
gether with granulocyte monocyte-colony stimulating
factor (GM-CSF), G-CSF, and other neutrophil survival
factors are suggested to prolong the survival of neutro-
phils, activate monocytes/macrophages, and contribute to
the formation of the pyogranulomatous lesions of FIP
[25]. In several human diseases, the most commonly iden-
tified genetic polymorphisms are located at position −238
and −308 of the promoter region of TNFA, suggesting an
effect on the binding of transcription factors [27], with
susceptibility for the development of several viral diseases,
including severe acute respiratory syndrome (SARS)
[28], dengue hemorrhagic fever (DHF) [29], and hepatitisSNPs harbored, including fIFNG +428, fTNFA - 421, and
f FIP
n-FIP number (%) P value OR (95% CI)
(58.1%) 0.002 Reference
(30.1%) 3.06 (1.36 - 6.88)
(11.8%) 6.01 (1.27 - 28.35)
(71.0%) 0.0059 Reference
(29.0%) 2.51 (1.32 - 4.80)
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gene (TNFA - 308), SNP located in a slightly upstream
region of the feline gene (fTNFA - 421) was found to be
significantly associated with the occurrence of FIP. The
variant fTNFA - 421 T allele was significantly associated
with resistance to FIP. Through DNA transcriptional fac-
tor binding site prediction, we found that an fTNFA - 421
C to T mutation might affect the binding of some tran-
scription factors, such as myeloid zinc finger 1 (MZF1)
[31], a transcriptional regulator [32]. Through promoter
binding, MZF1 was identified to function as a transcrip-
tion activator of hematopoietic cells in vitro [32]. Because
macrophages are hematopoietic cells, the loss of the bind-
ing site for such transcription factors might decrease TNF-α
production in macrophages, which might prevent the immu-
nopathogenesis and result in a resistant phenotype.
DC-SIGN, which recognizes high-mannose oligosaccha-
rides as its ligand, is a co-receptor augmenting many viral
infections, including human immunodeficiency virus [33],
dengue virus [34], HBV [35], and SARS-coronavirus [36].
In addition, feline DC-SIGN also serves as a co-receptor
and is involved in infection by FCoV [19]. A human
SNP in the promoter region of CD209 (−336 A/G) was
identified as related to disease prognosis [36]. A variant
of CD209 - 336 was reported to affect the binding of
SP1-like transcription factor and might modulate tran-
scriptional activities [34], indicating that CD209 - 336
plays a crucial role in disease pathogenesis. However, in
our study, none of the SNPs in the promoter region
showed an association with the outcome of FCoV infection.
The identified FIP-associated SNPs, +1900 G/A, +2276
C/T, +2392 G/A, and +2713 C/T, were all located at the
3′ end of fCD209. The polymorphism identified at
fCD209 + 1900 is located in the lectin binding domain
of the ECD; a G to A substitution leads to a change from
a tryptophan at amino acid 128 to a stop codon. This mu-
tation might lead to an abortive mRNA [37] or a truncated
protein if the mRNA is successfully translated. DC-SIGN
serves as a pattern recognition receptor that interact with
numerous pathogens, including FCoV, and mediates the
clustering of DC with naive T cells [38]. Additionally,
with a type II transmembrane domain, the truncated
fDC-SIGN identified in this study (+1900) might still be
expressed on the cell surface. However, it remains to be
elucidated how the truncated protein, bearing only one
half of the authentic protein, affect the normal function
of DC-SIGN, i.e., pathogen recognition or T cell activa-
tion. The other three FIP-associated SNPs were located
in introns 6 and 7. Although these polymorphisms are
located in introns, which apparently would not affect
the protein, a regulatory effect cannot be excluded. In
humans, the SNP at IFNG +874, located in intron 1, was
found to alter the binding activity of nuclear factor
kappa-light-chain-enhancer of activated B cells andinfluenced the production of IFN-γ [39]. In swine, an
SNP (G3072A) in intron 3 of insulin-like growth factor
2 affected the binding of muscle growth regulator and
was associated with the muscle content [40].
Several pedigreed cats, including Abyssinians, Himalayans,
Birmans, Bengals, Ragdolls, and Rexes, were reported to
have a higher incidence of FIP than other breed cats [2].
Recently, a genome-wide association study of Danish and
American Birman cats populations identified five SNPs
involved in FIP susceptibility [20]. However, none of these
SNPs showed a similar correlation in the present study,
concordant with the postulation by the authors that these
associations might only be relevant to Birman breed or
other breeds with similar genetic traits [24].
In addition to the three SNPs in fIFNG, we identified in
this study five more SNPs from two genes - one in fTNFA
and four in fCD209 - that are associated with the occur-
rence of FIP. As the susceptibility or resistance to viral
infections is a complex phenotype regulated by multiple
interacting genes and gene networks, genes related to
innate and adaptive immunity and other host genes re-
main to be pursued. The combination of all the FIP sus-
ceptibility genotypes into a single typing diagnosis assay
should facilitate the screening of FIP-resistant cats in
breeding and eventually decrease the loss of cats to this
incurable disease.
Additional files
Additional file 1: Frequencies of the fTNFA genotypes and alleles
and associations with the outcome of FCoV infection. The promoter
variant, fTNFA - 421 T, was found to be a disease-resistance genotype.
Additional file 2: Frequencies of the fCD209 genotypes and alleles
and associations with the outcome of FCoV infection. Polymorphisms
of fCD209, including fCD209 + 1900, + 2276, + 2392 and +2713, were
found to be significantly associated with the disease outcome.
Additional file 3: Frequencies of the genotypes and alleles of the
proposed FIP-associated SNPs in Birman cats and associations with FIP.
Neither the percentage of genotypes nor alleles was found to be associated
with the outcome of FCoV infection in disease and non-disease group.
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